Chandan Taparia of Motilal Oswal Securities has buy call on Sun Pharmaceutical Industries Ltd. with a target price of Rs 580.0 . The current market price of Sun Pharmaceutical Industries Ltd. is Rs 550.35 Time period given by analyst is Intra Day when Sun Pharmaceutical Industries Ltd. price can reach defined target. Chandan Taparia recommended to keep stoploss at Rs 535
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 132045.92 Crore) operating in Pharmaceuticals and health care sector.

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 7523.79 Crore to Sales Value (96.37 % of Total Sales) and Other Operating Revenue which contributed Rs 282.91 Crore to Sales Value (3.62 % of Total Sales)for the year ending 31-Mar-2017.

For the quarter ended 30-06-2017, the company has reported a Consolidated sales of Rs 6166.66 Crore, down -9.65 % from last quarter Sales of Rs 6825.16 Crore and down -22.98 % from last year same quarter Sales of Rs 8006.68 Crore Company has reported net profit after tax of Rs -320.70 Crore in latest quarter. The company's top management includes Mr.Ashwin Dani, Mr.Dilip S Shanghvi, Mr.Hasmukh S Shah, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Keki M Mistry, Mr.S Mohanchand Dadha, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Ms.Rekha Sethi. Company has Deloitte Haskins & Sells as its auditoRs As on 30-09-2017, the company has a total of 2,399,308,086 shares outstanding.